Thursday, December 9, 2021
3:00PM – 4:00PM ET
Please note this virtual program is 3:00PM Eastern, 2:00PM Central, 1:00PM Mountain and 12:00PM Pacific.
Michael J. Blaha, MD, MPH (CARDIOLOGIST)
Professor of Medicine and Epidemiology
Director of Clinical Research,
Ciccarone Center for the Prevention of Cardiovascular Disease
Johns Hopkins University School of Medicine
Jay Shubrook, DO, FACOFP, FAAFP (PRIMARY CARE)
Professor and Diabetologist
Director for Clinical Research
Director of Diabetes Service
After completing the CME activity, learners should be better able to:
- Determine the clinical implications of results from Cardiovascular Outcomes Trials of GLP-1 receptor agonists
- Identify patients with type 2 diabetes (T2DM) who are most likely to benefit from the use of GLP-1 receptor agonists
- Personalize the selection of GLP-1 receptor agonists based on indications, guidelines recommendations and clinical data
- Develop strategies for increasing collaboration between cardiologists and PCPs in managing cardiovascular risk in patients with T2DM
This educational activity is intended for cardiologists and primary care providers who manage and treat patients with type 2 diabetes.
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live virtual activity for a maximum of 1.0 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live virtual activity.
NURSING CREDIT INFORMATION
This program would be beneficial for nurses involved in the care of patients with type 2 diabetes mellitus.
1.0 ANCC Contact Hour
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]